网络首发:2015-12-20,
纸质出版:2015
移动端阅览
前列腺素E2体外主要通过活化受体EP4促进人CD34+ 细胞增殖[J]. 中山大学学报(医学科学版), 2015,36(6).
Prostaglandin E2 Promotes Human CD34+ Cells Proliferation through EP4 Prostanoid Receptor[J]. Journal of Sun Yat-sen University (Medical Sciences), 2015, 36(6).
摘 要: 【目的】 明确介导前列腺素E2(PGE2)促进人CD34+细胞增殖的具体受体亚型。【方法】 收集2013年6月至2014年10月期间18例健康志愿者经G-CSF动员的外周血,采用免疫磁珠法分选人CD34+细胞,并用流式细胞术鉴定其纯度;用qRT-PCR检测经PGE2作用后的人CD34+细胞中PGE2四个亚受体(EP1 ~ EP4)mRNA表达情况;根据处理方法不同,将人CD34+细胞分为对照组、前列腺素E2(PGE2)组、前列腺素E2受体EP2激动剂(EP2A)组、EP2A+前列腺素E2受体EP2拮抗剂(EP2AA)组、前列腺素E2受体EP4激动剂(EP4A)组及EP4A+前列腺素E2受体EP4拮抗剂(EP4AA)组,每组3例,分别接受上述组药物处理,采用集落形成实验检测红系集落形成单位CFU-E、红系爆式集落形成单位BFU-E、粒系集落形成单位CFU-G、单核系集落形成单位CFU-M、粒-单核系集落形成单位CFU-GM及粒、红、单核、巨核系集落形成单位CFU-GEMM集落形成情况;用流式细胞术检测细胞周期分布;用Real time-PCR检测CD34+细胞内survivin-mRNA水平、Western blot检测胞浆内β-catenin和survivin蛋白表达情况。【结果】 人CD34+细胞可表达PGE2的四个亚受体,但主要表达受体EP2和EP4;PGE2作用后,EP2和EP4 mRNA表达量较对照组明显升高,而EP1和EP3的mRNA表达变化不明显;EP4A可促进人CD34+细胞各系造血集落形成;EP4A可促进人 CD34+细胞进入细胞周期,使G2/M期比例增加; EP4A可促进凋亡抑制蛋白survivin的mRNA和蛋白表达、β-catenin蛋白表达。【结论】 前列腺素E2体外主要通过受体EP4促进人CD34+细胞增殖。
Abstract: 【Objective】 To identify the receptors involved in PGE2 promoting human CD34+cells proliferation. 【Methods】 18 samples of peripheral blood mobilized by G -CSF from 2013.6~2014.10 was collected. Human CD34+ cells were isolated by magnetic activated cell sorting (MACS) microbeads kits, and the purity of CD34+ cells was identified by flow cytometry. Four PGE2 receptors (EP1 ~ EP4) expressed on human CD34+ cells which were treated with dmPGE2 were detected by qRT -PCR. The human CD34+ cells were divided into 6 groups. Each group cells were treated with control, PGE2, EP2 agonist (EP2A), EP2A+EP2 antagonist (EP2AA), EP4 agonist (EP4A) and EP4A+EP4 antagonist (EP4AA), respectively. Twenty four hours later, burst forming unit -Erythrocyte (BFU -E) number, colony forming unit -Erythrocyte (CFU -E)number, colony forming unit -Granulocyte (CFU -G) number, colony forming unit -Monocyte (CFU -M) number, colony forming unit -Granulocyte monocyte (CFU -GM) number and colony forming unit-Granulocyte, Erythrocyte, Monocyte and Megakaryocyte (CFU -GEMM) were evaluated by colony -forming assay. Furthermore, cell cycle distribution was analyzed by flow cytometry, and the expression of survivin mRNA,β -catenin and survivin protein of human CD34+ cells was detected by qRT -PCR and Western blot,respectively. 【Results】 Human CD34+ cells could express four PGE2 receptors. While the relative expression of EP2 and EP4 mRNA were significantly higher than EP1 and EP3 mRNA. The EP2 and EP4 mRNA relative expression in human CD34+ cells which were treated with dmPGE2 were significantly up -regulated compared with control groups, while the EP1 and EP3 mRNA relative expression had no obviously changed. After exposured to PGE2, EP2A, EP2A+EP2AA,EP4A and EP4A+EP4AA, we observed that EP4A stimulates CFU -E, BFU -E, CFU -GEMM, CFU -G, CFU -M and CFU -GM formation, while EP4AA plays a negative effects on those colony formations. We also found that EP4A induces human CD34+ cells entering into cell cycle (G2/M phase) from rest period (G0/G1 phase). In addition, we found that EP4A elevates survivin mRNA, survivin and β -catenin protein expression by real time -PCR and Western blot analysis. 【Conclusion】 PGE2 enhancing human CD34+ cells proliferation could mainly mediate by EP4 prostanoid receptor.
0
浏览量
257
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
